Ji Young Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ji Young Kim has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Yong Sik Jung
Department of Surgery, Ajou University School of Medicine, Suwon, South Korea
5 shared publications - Doo Kyoung Kang
Department of Radiology, Ajou University School of Medicine, Suwon, Korea
3 shared publications - Tae Hee Kim
Department of Radiology, Ajou University Medical Center, Suwon, Korea
3 shared publications - Jin-Hee Park
College of Nursing, Research Institute of Nursing Science, Ajou University, Suwon, Republic of Korea
2 shared publications - Sun Hyoung Bae
College of Nursing, Research Institute of Nursing Science, Ajou University, Suwon, Republic of Korea
2 shared publications - Young-Sil An
Department of Nuclear Medicine, Ajou University Medical Center, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea
2 shared publications
Latest Publications
- Open Access
- 10 January 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-10
Trajectories of quality of life in breast cancer survivors during the first year after treatment: a longitudinal study
Background: Although quality of life (QOL) improves over time for most breast cancer patients after their treatment, some patients may show different patterns of QOL. Beyond determining distinct QOL trajectories, identifying characteristics of patients who have different trajectories can help identify breast cancer patients who may benefit from intervention. We aimed to identify trajectories of QOL in breast cancer patients for one year after the end of primary treatment, to determine the factors influencing these changes. Methods: This longitudinal study recruited 140 breast cancer patients. Patients' QOL, symptom experience, self-efficacy, and social support were assessed using the Functional Assessment of Cancer Therapy Scale-G, Memorial Symptom Assessment Scale-Short Form, Self-Efficacy Scale for Self-Management of Breast Cancer, and Interpersonal Support Evaluation List-12. Data were collected immediately after the end of primary treatment (T1) and at three (T2), six (T3), and 12 months (T4) after primary treatment. Group-based trajectory modeling was used to identify distinct subgroups of patients with similar patterns of QOL change after treatment. A one-way analysis of variance was used to determine which variables were associated with trajectory membership. A multinomial logistic regression was performed to identify factors associated with trajectory group membership. Results: We analyzed 124 patients (mean age: 48.75 years). Latent class analysis of the QOL identified three trajectory groups: the low QOL group (n = 27; 21.1%), moderate QOL group (n = 57; 45.3%), and high QOL group (n = 40; 33.6%). The low QOL group showed consistently low QOL after the end of primary treatment, and the moderate QOL group showed a slight decrease in QOL from T1 to T3, which returned to the T1 level at T4. The high QOL group maintained a consistently high QOL. By multinomial logistic regression, psychological symptoms (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.22–0.99) predicted a moderate QOL, and both psychological symptoms (OR 0.19, 95% CI 0.07–0.51) and belonging support (OR 1.60, 95% CI 1.06–2.39) predicted a high QOL. Conclusion: Identifying high-risk groups for reduced QOL after the end of primary treatment is necessary. Moreover, psychosocial interventions should be provided to alleviate psychological symptoms and increase belonging support to enhance patients' QOL. Trial registration Not registered.
- 10 January 2023
- Published by Springer Nature in BMC Women's Health
- Vol. 23 (1) , 1-10
Open AccessTrajectories of quality of life in breast cancer survivors during the first year after treatment: a longitudinal study
Background: Although quality of life (QOL) improves over time for most breast cancer patients after their treatment, some patients may show different patterns of QOL. Beyond determining distinct QOL trajectories, identifying characteristics of patients who have different trajectories can help identify breast cancer patients who may benefit from intervention. We aimed to identify trajectories of QOL in breast cancer patients for one year after the end of primary treatment, to determine the factors influencing these changes. Methods: This longitudinal study recruited 140 breast cancer patients. Patients' QOL, symptom experience, self-efficacy, and social support were assessed using the Functional Assessment of Cancer Therapy Scale-G, Memorial Symptom Assessment Scale-Short Form, Self-Efficacy Scale for Self-Management of Breast Cancer, and Interpersonal Support Evaluation List-12. Data were collected immediately after the end of primary treatment (T1) and at three (T2), six (T3), and 12 months (T4) after primary treatment. Group-based trajectory modeling was used to identify distinct subgroups of patients with similar patterns of QOL change after treatment. A one-way analysis of variance was used to determine which variables were associated with trajectory membership. A multinomial logistic regression was performed to identify factors associated with trajectory group membership. Results: We analyzed 124 patients (mean age: 48.75 years). Latent class analysis of the QOL identified three trajectory groups: the low QOL group (n = 27; 21.1%), moderate QOL group (n = 57; 45.3%), and high QOL group (n = 40; 33.6%). The low QOL group showed consistently low QOL after the end of primary treatment, and the moderate QOL group showed a slight decrease in QOL from T1 to T3, which returned to the T1 level at T4. The high QOL group maintained a consistently high QOL. By multinomial logistic regression, psychological symptoms (odds ratio [OR] 0.46, 95% confidence interval [CI] 0.22–0.99) predicted a moderate QOL, and both psychological symptoms (OR 0.19, 95% CI 0.07–0.51) and belonging support (OR 1.60, 95% CI 1.06–2.39) predicted a high QOL. Conclusion: Identifying high-risk groups for reduced QOL after the end of primary treatment is necessary. Moreover, psychosocial interventions should be provided to alleviate psychological symptoms and increase belonging support to enhance patients' QOL. Trial registration Not registered.
- Open Access
- 1 January 2022
- Published by XMLink in Journal of Breast Cancer
- Vol. 25 (2) , 94-105
Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
Ryu JM, et al. J Breast Cancer. 2022 Apr;25(2):94-105. https://doi.org/10.4048/jbc.2022.25.e17
- 1 January 2022
- Published by XMLink in Journal of Breast Cancer
- Vol. 25 (2) , 94-105
Open AccessRelationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society
Ryu JM, et al. J Breast Cancer. 2022 Apr;25(2):94-105. https://doi.org/10.4048/jbc.2022.25.e17
- Open Access
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (6) , 635-646
In Vitro Analysis of Histology, Mechanics, and Safety of Radiation-free Pre-hydrated Human Acellular Dermal Matrix
Kim JY, et al. J Breast Cancer. 2019 Nov;23:e64. https://doi.org/10.4048/jbc.2020.23.e64
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (6) , 635-646
Open AccessIn Vitro Analysis of Histology, Mechanics, and Safety of Radiation-free Pre-hydrated Human Acellular Dermal Matrix
Kim JY, et al. J Breast Cancer. 2019 Nov;23:e64. https://doi.org/10.4048/jbc.2020.23.e64
- Open Access
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (1) , 80-92
Prognostic Value of Skeletal Muscle Depletion Measured on Computed Tomography for Overall Survival in Patients with Non-Metastatic Breast Cancer
Huh J, et al. J Breast Cancer. 2019 Nov;23:e8. https://doi.org/10.4048/jbc.2020.23.e8
- 1 January 2020
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 23 (1) , 80-92
Open AccessPrognostic Value of Skeletal Muscle Depletion Measured on Computed Tomography for Overall Survival in Patients with Non-Metastatic Breast Cancer
Huh J, et al. J Breast Cancer. 2019 Nov;23:e8. https://doi.org/10.4048/jbc.2020.23.e8
- Open Access
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 635-640
Intraoperative Specimen Mammography for Margin Assessment in Breast-Conserving Surgery
Jin M, et al. J Breast Cancer. 2019 Jul;22:e58. https://doi.org/10.4048/jbc.2019.22.e58
- 1 January 2019
- Published by XMLink in Journal of Breast Cancer
- Vol. 22 (4) , 635-640
Open AccessIntraoperative Specimen Mammography for Margin Assessment in Breast-Conserving Surgery
Jin M, et al. J Breast Cancer. 2019 Jul;22:e58. https://doi.org/10.4048/jbc.2019.22.e58
- Open Access
- 1 January 2019
- Published by Korean Oncology Nursing Society in Asian Oncology Nursing
- Vol. 19 (2) , 90-97
Menopausal Symptoms and Quality of Life Among Breast Cancer Patients with Chemotherapy-induced Amenorrhea
- 1 January 2019
- Published by Korean Oncology Nursing Society in Asian Oncology Nursing
- Vol. 19 (2) , 90-97
Open AccessMenopausal Symptoms and Quality of Life Among Breast Cancer Patients with Chemotherapy-induced Amenorrhea
- Open Access
- 1 January 2017
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 20 (4) , 386-392
Metabolic Activity of Normal Glandular Tissue on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Correlation with Menstrual Cycles and Parenchymal Enhancements
The aims of our study were to correlate the degree of metabolic activity in normal glandular tissue measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) with qualitative background parenchymal enhancement (BPE) grades on magnetic resonance imaging (MRI), and to investigate the change in standardized uptake value (SUV) according to the patients' menstrual cycles. From January 2013 to December 2015, 298 consecutive premenopausal patients with breast cancer who underwent both breast MRI and 18F-FDG PET/CT were identified. BPE was evaluated in the contralateral breast of cancer patients and categorized as minimal, mild, moderate, or marked based on Breast Imaging Reporting and Data System criteria. We analyzed the correlation between BPE and maximum SUV (SUVmax) and mean SUV (SUVmean) values. We also analyzed the metabolic activity of normal glandular tissue according to the patients' menstrual cycles. The mean SUVmax and SUVmean values differed significantly according to BPE grade (ppp<0.001). The mean SUVmax and SUVmean values differed significantly according to the patients' menstrual cycles, with the highest values in the 3rd week and the lowest value in the 2nd week. Of 29 patients with low metabolic parenchyma (high BPE but low SUVmean values), 17 (58.6%) were in the 4th week of their menstrual cycle. The metabolic activity of normal breast parenchyma, which is highest in the 3rd week and lowest in the 2nd week of the menstrual cycle, correlates moderately with BPE on MRI. Metabolic activity tends to be lower than blood flow and vessel permeability in the 4th week of the menstrual cycle.
- 1 January 2017
- Published by Korean Breast Cancer Society in Journal of Breast Cancer
- Vol. 20 (4) , 386-392
Open AccessMetabolic Activity of Normal Glandular Tissue on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Correlation with Menstrual Cycles and Parenchymal Enhancements
The aims of our study were to correlate the degree of metabolic activity in normal glandular tissue measured on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) with qualitative background parenchymal enhancement (BPE) grades on magnetic resonance imaging (MRI), and to investigate the change in standardized uptake value (SUV) according to the patients' menstrual cycles. From January 2013 to December 2015, 298 consecutive premenopausal patients with breast cancer who underwent both breast MRI and 18F-FDG PET/CT were identified. BPE was evaluated in the contralateral breast of cancer patients and categorized as minimal, mild, moderate, or marked based on Breast Imaging Reporting and Data System criteria. We analyzed the correlation between BPE and maximum SUV (SUVmax) and mean SUV (SUVmean) values. We also analyzed the metabolic activity of normal glandular tissue according to the patients' menstrual cycles. The mean SUVmax and SUVmean values differed significantly according to BPE grade (ppp<0.001). The mean SUVmax and SUVmean values differed significantly according to the patients' menstrual cycles, with the highest values in the 3rd week and the lowest value in the 2nd week. Of 29 patients with low metabolic parenchyma (high BPE but low SUVmean values), 17 (58.6%) were in the 4th week of their menstrual cycle. The metabolic activity of normal breast parenchyma, which is highest in the 3rd week and lowest in the 2nd week of the menstrual cycle, correlates moderately with BPE on MRI. Metabolic activity tends to be lower than blood flow and vessel permeability in the 4th week of the menstrual cycle.